AGENUS INC (AGEN)
2025-03-31 | 2024-09-30 | |||
|---|---|---|---|---|
| Total revenues | 24,066 | 25,112 | ||
| Research and development | 21,522 | 41,058 | ||
| General and administrative | 15,718 | 17,275 | ||
| Cost of service revenue | 137 | 146 | ||
| Fair value adjustments | - | 1,863 | ||
| Operating loss | -13,311 | -31,504 | ||
| Non-operating expense | -264 | 19 | ||
| Interest expense, net | -12,795 | -35,729 | ||
| Net loss | -26,370 | -67,214 | ||
| Dividends on series a-1 convertible preferred stock | 54 | 54 | ||
| Less net loss attributable to non-controlling interest | -1,104 | -828 | ||
| Net loss attributable to agenus inc. common stockholders | -25,320 | -66,440 | ||
| Foreign currency translation loss | -70 | -346 | ||
| Other comprehensive loss | -70 | -346 | ||
| Comprehensive loss | -25,390 | -66,786 | ||
| Basic eps | -1.03 | -3.08 | ||
| Diluted eps | -1.03 | -3.08 | ||
| Basic average shares | 24,469,000 | 21,550,000 | ||
| Diluted average shares | 24,469,000 | 21,550,000 | ||